hrp0089fc12.6 | Diabetes and Insulin 2 | ESPE2018

Persistent Beneficial Effects of Metformin in Children and Adolescents with Type 1 Diabetes: Adelaide Metformin Randomized Controlled Trial Follow Up

Maftei Oana , Couper Jennifer , Anderson Jemma , Ricci Peter , Gent Roger , Giles Lynne , Pena Alexia

Puberty is a critical period for the development and acceleration of vascular complications in Type 1 diabetes (T1D). We have shown that metformin in addition to insulin improves vascular smooth muscle function and HbA1c in T1D children over 12 months (1). We aimed to determine if children with T1D who received metformin in a randomized controlled trial (RCT) [Trial registration ACTRN126110001148976] have a sustained vascular function improvement 3 years after ceasing metformi...

hrp0089p2-p131 | Fat, Metabolism and Obesity P2 | ESPE2018

Visfatin, RBP4 and STRA6 polymorphisms’ in relation with Childhood Obesity

Pascanu Ionela , Pop Raluca , Vasilache Simona , Marginean Oana , Moldovan Valeriu , Banescu Claudia

Background: Several visfatin, retinol binding protein 4(RBP4) and high affinity receptor for RBP4, STRA6 (stimulated by retinoic acid) single nuclear polymorphisms’ (SNP) have been investigated regarding their relationship with obesity with controversial results.Aim: To analyze the association of two specific SNP for visfatin, RBP4 and STRA6 with anthropometric markers of obesity in children.Material and method: A case control...

hrp0086p2-p718 | Endocrinology and Multisystemic Diseases P2 | ESPE2016

Endocrine and Metabolic Evaluation of Children with Neurodevelopmental Disability

Brad Giorgiana-Flavia , Marcovici Tamara , Belei Oana , Bizerea Teofana , Mang Niculina , Tamasanu Raluca , Marginean Otilia

Introduction: Neurodevelopmental disability (NDD) is a common problem in children health, occurring in 5–10% of the pediatric population.Aim: To evaluate the endocrine and metabolic complications described in patients with NDD.Material and method: Children with NDD, aged below 9 years old, admitted to 1st Pediatric Clinic of Children Emergency Hospital, Timişoara, România, between January 2014-March 2016 w...

hrp0084p3-990 | Gonads | ESPE2015

The Consequences of Polycystic Ovary Syndrome in Adolescent Girls

Brad Giorgiana Flavia , Marcovici Tamara , Belei Oana , Popoiu Calin , Olariu Laura , David Vlad , Marginean Otilia

Background: Polycystic ovary syndrome (PCOS) represents one of the most common complains for adolescent girls to present to endocrinologist. PCOS has the potential to affect the young person both metabolically, physically, psychologically and socially.Objective: To evaluate the metabolic and psychological consequences of PCOS in adolescent girls.Method: Adolescent girls admitted in the Endocrinology Department of Children Emergency...

hrp0095p2-81 | Diabetes and Insulin | ESPE2022

Steroid-induced diabetes mellitus in children and adolescents: risk factors, course features, treatment specifics and prognosis on example of 10 patients

Frolova Elena , Shirokova Irina , Makretskaya Nina

Background: SIDM is not a common complication of high-dose glucocorticoid therapy (HD-GC) in pediatric practice. There are no clear generally accepted approaches to SIDM treatment. In 10 cases, we present the identified patterns of predictors, course, features of the treatment of SIDM in children and adolescents.Methods: 10 case histories of children with SIDM were analyzed. 4 boys, 6 girls, age 8-17.5 years, median 15 y...

hrp0095p2-189 | Growth and Syndromes | ESPE2022

Does she need growth hormone treatment?

Elkina Stanimira , Halvadzhiyan Irina , Petrova Chayka

Growth retardation in children with type 1 diabetes (T1D) is mostly associated with longterm poor metabolic control or combination with other autoimmune diseases. Although rare it could be due to growth hormone deficiency. We present eleven-year-old girl, diagnosed with T1D at age of 2y6mo., on multiple daily injections (MDI) with analogues. She is raised in poor social conditions – low parental education and income, rare follow-up due to difficult access to healthcare p...

hrp0092p1-78 | GH and IGFs | ESPE2019

Premature Infants Born Small by Gestational Age: the Role of Insulin-like Growth Factor-1 in the Regulation of Postnatal Growth

Kovalenko Tatyana , Yuditskiy Anton , Petrova Irina

The role of insulin-like growth factor-1 (IGF-1) in the regulation of growth of children with intrauterine growth is currently being discussed, but the final point of view has not been achieved.Aim: to study the effect of IGF-1 in the dynamics of postnatal growth of premature infants with SGA in the first 5 years of life.Material and Methods: The prospective study included prematurity with SGA (gro...

hrp0092p2-185 | Growth and Syndromes (to include Turner Syndrome) | ESPE2019

Premature Infants Born Small to Gestational Age: Growth Dynamics in the First 5 Years of Life

Yuditskiy Anton , Kovalenko Tatyana , Petrova Irina

Prematurity combined with intrauterine growth retardation (small to gestational age, SGA) is a potential risk factor for adverse growth prognosis. There is insufficient evidence on this issue.Aim: to study the growth rates in preterm infants born small to gestational age, different gestational age in the first 5 years of life.Material and Methods: The prospective study included preterm infants with...

hrp0089p2-p019 | Adrenals and HPA Axis P2 | ESPE2018

Two Cases of Apparent Mineralocorticoid Excess due to Novel Mutations in HSD11B2 Gene

Makretskaya Nina , Kostrova Irina , Tiulpakov Anatoly

Background: Human HSD11B2 metabolizes active cortisol into cortisone and protects the mineralocorticoid receptor from glucocorticoid occupancy. Loss of function mutations in HSD11B2 gene cause a rare autosomal recessive disorder, apparent mineralocorticoid excess, resulting in low-renin hypertension and hypokalemia.Objective: We present 2 children with apparent mineralocorticoid excess. Case 1, a boy presenting at 11 yea...

hrp0089p1-p151 | GH & IGFs P1 | ESPE2018

Growth of Premature Infants Born Small by Gestational Age

Kovalenko Tatyana , Yuditskiy Anton , Petrova Irina

Premature infants born small by gestational age (SGA) represent a potential cohort for growth retardation. However, up to the present time, questions of the frequency and severity of the growth deficit, the timing of the growth rate, the age of achievement of the population standard depending on the gestational age have been discussed.Aim: To assess the dynamics of growth of preterm infants born small by gestational age within 5 years of life, taking int...